san-francisco_image

Innovation and progress are core ingredients in today’s financial ecosystem, especially in the fields of health care and life sciences.  Greenberg Traurig has a renowned healthcare practice, serving many
Continue Reading GT Events during the 2016 JPMorgan Healthcare Conference & the 9th Annual OneMedForum in San Francisco

A solar water heater on every Israeli rooftop
A solar water heater on every Israeli rooftop

Israel is a garden of inventiveness and Israelis have a strong tradition of contributing to technology and life sciences. Breathing the innovation when I lived there, I was privileged to test PrimeSense’s 3D camera, help bring Notal Vision’s tool to gauge macular degeneration to the United States, deliver a turn-key VoIP network in Nigeria and Zambia on behalf of VocalTec, license ecommerce and security software to dozens of Fortune 100 companies, watch knee surgery with miraculous tissue-repairing Regentis hydrogel, play with a gear box created from an Objet (now Stratasys) 3D printer, and negotiate sponsored research, patent licenses and clinical trials on behalf of emerging pharmaceutical companies.

Figuring out what gives rise to the “start-up nation” character, with wildly disproportionate foreign direct investment and numbers of translated books, cited academics, filed patents, Nasdaq companies, successful exits, and tuneful children’s songs, is a pervasive new-age question. Many answers have been floated, including its world-class research institutions, the very first technology transfer offices for commercialization of academic R&D, raw skills honed in one of the best-trained and most-sophisticated militaries, a culture of questioning, and a flood of ex-Soviet engineering talent over three decades. Naturally one can’t discount that there are real issues to be addressed too. Israelis have done it — from discerning security risks through synthesis of big data to making the desert bloom with fruit, vegetables, fish, and minerals.
Continue Reading Ingenuity in Israel’s Water

shutterstock_31312693-300x200Israel is home to more than 750 medical device companies, 300 pharmaceutical/biotech companies, and 170 other life science or healthcare IT companies. David Dykeman, co-chair of Greenberg Traurig’s  Life Science & Medical Technology Group, describes Israel as a “biomedical and healthcare powerhouse.”

David recently led a delegation of New England executives and investors from the biomedical, healthcare and life science sectors to spend three days exploring Israeli  innovation and commercialization, learning about Israel’s cutting edge medical technology and investment trends, and speaking with executives of Israeli companies. In return, Israeli executives learned more about why Boston – with its own tech innovation, renowned universities and venture capital investors – is a natural fit for Israeli companies looking to enter the U.S. market.Continue Reading New England Executives Get an Inside Look at Israeli Innovation

The 33rd Annual J.P. Morgan Healthcare Conference & Biotech Showcase was held in January in San Francisco, Calif. The conference is the biggest health care investing event of the year, attracting thousands of medical device, biotechnology, and pharmaceutical executives and investors in attendance from around the world. Numerous Israeli companies participated in the conference, including a group of seven health care technology companies that presented at the Health Evolution Summit, “Connecting Health Leaders.”

More than 30 Greenberg Traurig attorneys from offices around the world attended the conference to provide support to existing clients and forge new connections. In attendance from the firm’s Israel Practice were  Bob Grossman, co-chair of the Israel Practice, David Dykeman, co-chair of the firm’s Life Sciences & Medical Technology Group, and  Roman Fayerberg, an IP shareholder in the Boston office.Continue Reading Greenberg Traurig Attorneys Participate in J.P. Morgan Healthcare Conference & Biotech Showcase